<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu Y</submitter><funding>Intramural NIH HHS</funding><pagination>507-518</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4174543</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>371(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The study of autoinflammatory diseases has uncovered mechanisms underlying cytokine dysregulation and inflammation.&lt;h4>Methods&lt;/h4>We analyzed the DNA of an index patient with early-onset systemic inflammation, cutaneous vasculopathy, and pulmonary inflammation. We sequenced a candidate gene, TMEM173, encoding the stimulator of interferon genes (STING), in this patient and in five unrelated children with similar clinical phenotypes. Four children were evaluated clinically and immunologically. With the STING ligand cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), we stimulated peripheral-blood mononuclear cells and fibroblasts from patients and controls, as well as commercially obtained endothelial cells, and then assayed transcription of IFNB1, the gene en</pubmed_abstract><journal>The New England journal of medicine</journal><pubmed_title>Activated STING in a vascular and pulmonary syndrome.</pubmed_title><pmcid>PMC4174543</pmcid><funding_grant_id>ZIA AR041138</funding_grant_id><pubmed_authors>Hill S</pubmed_authors><pubmed_authors>Brooks SR</pubmed_authors><pubmed_authors>Trier AM</pubmed_authors><pubmed_authors>Boehm M</pubmed_authors><pubmed_authors>Deng Z</pubmed_authors><pubmed_authors>Plass N</pubmed_authors><pubmed_authors>Barysenka A</pubmed_authors><pubmed_authors>DiMattia MA</pubmed_authors><pubmed_authors>Kastner DL</pubmed_authors><pubmed_authors>Jesus AA</pubmed_authors><pubmed_authors>DiGiovanna JJ</pubmed_authors><pubmed_authors>Marrero B</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>St Hilaire C</pubmed_authors><pubmed_authors>Candotti F</pubmed_authors><pubmed_authors>Paller AS</pubmed_authors><pubmed_authors>Sanchez GAM</pubmed_authors><pubmed_authors>Stone DL</pubmed_authors><pubmed_authors>Minniti CP</pubmed_authors><pubmed_authors>Gonzalez B</pubmed_authors><pubmed_authors>Biancotto A</pubmed_authors><pubmed_authors>Tsai WL</pubmed_authors><pubmed_authors>Tenbrock K</pubmed_authors><pubmed_authors>Kim H</pubmed_authors><pubmed_authors>Wittkowski H</pubmed_authors><pubmed_authors>Fleisher TA</pubmed_authors><pubmed_authors>Lee CR</pubmed_authors><pubmed_authors>Gadina M</pubmed_authors><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Raffeld M</pubmed_authors><pubmed_authors>Fontana JR</pubmed_authors><pubmed_authors>Hughes JD</pubmed_authors><pubmed_authors>McElwee J</pubmed_authors><pubmed_authors>Kuehn HS</pubmed_authors><pubmed_authors>Holland SM</pubmed_authors><pubmed_authors>Foell D</pubmed_authors><pubmed_authors>Ramsey SE</pubmed_authors><pubmed_authors>Mehmet H</pubmed_authors><pubmed_authors>Kim HJ</pubmed_authors><pubmed_authors>Gurprasad S</pubmed_authors><pubmed_authors>Cowen EW</pubmed_authors><pubmed_authors>Rosenzweig SD</pubmed_authors><pubmed_authors>Goldbach-Mansky R</pubmed_authors><pubmed_authors>Moir S</pubmed_authors><pubmed_authors>Steven AC</pubmed_authors><pubmed_authors>Horkayne-Szakaly I</pubmed_authors><pubmed_authors>Jones OY</pubmed_authors><pubmed_authors>Issekutz AC</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Wingfield PT</pubmed_authors><pubmed_authors>Chapelle D</pubmed_authors><pubmed_authors>Palmer I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Activated STING in a vascular and pulmonary syndrome.</name><description>&lt;h4>Background&lt;/h4>The study of autoinflammatory diseases has uncovered mechanisms underlying cytokine dysregulation and inflammation.&lt;h4>Methods&lt;/h4>We analyzed the DNA of an index patient with early-onset systemic inflammation, cutaneous vasculopathy, and pulmonary inflammation. We sequenced a candidate gene, TMEM173, encoding the stimulator of interferon genes (STING), in this patient and in five unrelated children with similar clinical phenotypes. Four children were evaluated clinically and immunologically. With the STING ligand cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), we stimulated peripheral-blood mononuclear cells and fibroblasts from patients and controls, as well as commercially obtained endothelial cells, and then assayed transcription of IFNB1, the gene en</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Aug</publication><modification>2026-05-03T11:55:51.724Z</modification><creation>2019-03-27T01:36:20Z</creation></dates><accession>S-EPMC4174543</accession><cross_references><pubmed>25029335</pubmed><doi>10.1056/nejmoa1312625</doi><doi>10.1056/NEJMoa1312625</doi></cross_references></HashMap>